An Experimental Study to Optimize Neuromuscular Blockade Protocols in Cynomolgus Macaques: Monitoring, Doses, and Antagonism
These results support the use of non-human primate models for neuromuscular block monitoring. This represented the first step before the forthcoming testing of new NMBA-reversal agents.
Authors
- Francis Relouzat (ORCID: https://orcid.org/0000-0002-6387-8481)
- Pierre Bruhns (ORCID: https://orcid.org/0000-0002-4709-8936)
- Roger Le Grand (ORCID: https://orcid.org/0000-0002-4928-4484)
- Aurélie Gouél‐Cheron (ORCID: https://orcid.org/0000-0003-2648-1693)
- Julien Lemaître (ORCID: https://orcid.org/0000-0001-6239-0110)
- Hélène Letscher (ORCID: https://orcid.org/0000-0002-9202-6368)
- Emma Burban (ORCID: https://orcid.org/0009-0006-3373-2891)
Institutions
- Inserm (FR)
- Institut Pasteur (FR)
- Université Paris Cité (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Université Paris-Saclay (FR)
- CEA Paris-Saclay (FR)
- Infectious Disease Models and Innovative Therapies (FR)
- Hôpital Bichat-Claude-Bernard (FR)
Publication Details
- Journal
- Journal of Medical Primatology
- Published
- 2024-09-22
- DOI
- https://doi.org/10.1111/jmp.12736
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Labex Immuno-Oncology